Login / Signup

Birth outcomes in women who have taken adalimumab in pregnancy: A prospective cohort study.

Christina D ChambersDiana L JohnsonRonghui XuYunjun LuoJanina Lopez-JimenezMargaret P AdamStephen R BraddockLuther K RobinsonKeith VauxKenneth Lyons Jonesnull null
Published in: PloS one (2019)
Adalimumab exposure in pregnancy compared to diseased unexposed pregnancies was not associated with an increased risk for any of the adverse outcomes examined. Women with rheumatoid arthritis or Crohn's Disease were at increased risk of preterm delivery, irrespective of adalimumab exposure.
Keyphrases